| Product Name | MF | CAS | Details |
|---|
| KITLG Blocking Peptide | Details |
| PH 797804 | C22H19BrF2N2O3 | 586379-66-0 | Details |
| LY2157299 | C22H19N5O | 700874-72-2 | Details |
| DBPR108 | C16H25FN4O2 | 1186426-66-3 | Details |
| 7,7-Dimethyl-1,4-thiazepane | C7H15NS | 1428233-55-9 | Details |
| 6-Bromo-1,4-dimethyl-1H-1,3-benzodiazole | C9H9BrN2 | 1354757-31-5 | Details |
| 1-[2-(Morpholin-4-yl)ethyl]piperidin-4-one | C11H20N2O2 | 51137-77-0 | Details |
| Dimethyl-1H-1,2,4-triazol-5-amine hydroiodide | C4H9IN4 | 1461709-07-8 | Details |
| 5-((3,4-dichlorophenyl)diazenyl)-2,2-dimethyl-1,3-dioxane-4,6-dione | C12H10Cl2N2O4 | 1024861-10-6 | Details |
| (5-Propoxy-1H-indol-3-yl)methanol | C12H15NO2 | 215997-83-4 | Details |
| 2-Chloro-N-[3-(thiomorpholin-4-ylmethyl)phenyl]acetamide hydrochloride | C13H17N2OSCl·HCl | 1221723-47-2 | Details |
| 1,2,3,4-Tetra-O-acetyl-L-fucopyranose | C14H20O9 | 24332-95-4 | Details |
| 3-(4-Iodophenyl)piperazin-2-one | C10H11IN2O | 1869195-99-2 | Details |
| cis-6-Amino-cyclohex-3-enecarboxylic acid hydrochloride | C7H12ClNO2 | 57266-56-5 | Details |
| Mozavaptan HCl | C27H29N3O2.ClH | 138470-70-9 | Details |
| (1R,2S)-1-(6-Bromo-2-methoxyquinolin-3-yl) -4-(dimethylamino)-2-(naphthalen-1-yl) -1-phenylbutan-2-ol | C32H31BrN2O2 | 843663-66-1 | Details |
| 3-Deoxy-3,3-difluoro-1,2-O-Di-O-isopropylidene-a-D-glucofuranose | C9H14F2O5 | Details |
| 6-(Methoxymethyl)-2-(pyrrolidin-1-yl)-3,4-dihydropyrimidin-4-one | C10H15N3O2 | 1241669-65-7 | Details |
| 2-(Pyridin-2-yloxy)ethan-1-ol | C7H9NO2 | 56446-64-1 | Details |
| 1-Ethyl-4-iodo-5-(trifluoromethyl)-1H-pyrazole | C6H6F3IN2 | 1443279-73-9 | Details |
| 6-Mercaptopurine | C5H4N4S | 50-44-2 | Details |
| 6-Amino-1-(2-ethoxyethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione | C8H13N3O3 | 1154557-84-2 | Details |
| 4-Bromo-1H-indazol-5-ol | C7H5BrN2O | 478838-52-7 | Details |
| [2-(2-Methyl-1H-imidazol-1-yl)ethyl]aminedihydrochloride | C6H13Cl2N3 | 858513-10-7 | Details |
| (S)-8-Methoxy-N-propyl-2-aminotetraline hydrochloride | C14H22ClNO | 78095-35-9 | Details |
| 2-[3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]aniline | C14H14F3N3 | 937607-82-4 | Details |
| tert-butyl N-{[3-(aminomethyl)phenyl]methyl}-N-methylcarbamate | C14H22N2O2 | 954238-64-3 | Details |
| tert-Butyl N-(1-methoxy-2-oxoazetidin-3-yl)carbamate | C9H16N2O4 | 1822344-58-0 | Details |
| Methyl isocostate | C16H24O2 | 132342-55-3 | Details |
| 4-Pentenyl 2,4-di-O-(3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido b-D-glucopyranosyl)-3,6-di-O-benzyl-a-D-mannopyranoside | C65H70N2O24 | Details |
| 2-(1H-Imidazol-2-yl)aniline | C9H9N3 | 29528-25-4 | Details |
| IRAK inhibitor 6 | C20H20N4O3S | 1042672-97-8 | Details |
| L-α-Lysophosphatidylcholine | NULL | 9008-30-4 | Details |
| Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)Pro)-OH | C34H38N2O7 | 878797-09-2 | Details |
| 2-{[(tert-Butoxy)carbonyl]amino}-2-(2,4-difluorophenyl)acetic acid | C13H15F2NO4 | 1025496-16-5 | Details |
| H-IDIDIER-OH | Details |
| 3,3-difluoropiperidin-4-ol hydrochloride | C5H10ClF2NO | 1334416-77-1 | Details |
| ODC antibody | Details |
| 1-Hexadecanol | C16H34O | 36653-82-4 | Details |
| H-SGDSEVYQLGDVSQK-OH | Details |
| H-YLMPGFIHL-OH | Details |
| 2'-Deoxy-2',2'-difluorouridine | C9H10F2N2O5 | 114248-23-6 | Details |
| RLN3 | Details |
| Propargyl-PEG5-Tos | C18H26O7S | 875770-32-4 | Details |
| {2-[4-(Benzyloxy)phenoxy]ethyl}(methyl)amine | C16H19NO2 | 1001587-28-5 | Details |
| 2-Amino-1-(2-methylphenyl)ethan-1-ol | C9H13NO | 133562-34-2 | Details |
| Nevadensin | C18H16O7 | 10176-66-6 | Details |
| Hydantoin-5-13C,1-15N | C3H4N2O2 | 1189697-61-7 | Details |
| 4-Fluoro-1H-benzo[d]imidazol-2-amine | C7H6FN3 | 1249526-67-7 | Details |
| ADAMTS19 antibody | Details |
| Cyclohept-4-enecarboxylic acid | C8H12O2 | 1614-73-9 | Details |
| Potassium pivalate | C5H11KO2 | 19455-23-3 | Details |
| 3-Fluoro-4-(methylsulphonyl)benzaldehyde | C8H7FO3S | 254878-95-0 | Details |
| CEP-40783 | C31H26F2N4O6 | 1437321-24-8 | Details |
| 1-Ethyl-3-hydroxypiperidine | C7H15NO | 13444-24-1 | Details |
| 2'-Deoxycytidine-3'-monophosphate | C9H14N3O7P | 6220-63-9 | Details |
| 3-Fluoro-4-nitroaniline | C6H5FN2O2 | 2369-13-3 | Details |
| Modotuximab | 1310460-86-6 | Details |
| N-(2-Chloroacetyl)-1-methyl-1H-pyrrole-2-carboxamide | C8H9ClN2O2 | 730950-20-6 | Details |
| Barbatic acid | C19H20O7 | 17636-16-7 | Details |
| LB-100 | C13H20N2O4 | 1632032-53-1 | Details |
| Oxanosine | C10H12N4O6 | 80394-72-5 | Details |
| 4-[(2-Methylpropan-2-yl)oxycarbonylamino]-2-oxabicyclo[2.2.2]octane-1-carboxylic acid | C13H21NO5 | 2010218-26-3 | Details |
| 4-(Aminomethyl)-2,6-difluorophenol hydrobromide | C7H8BrF2NO | 2060062-39-5 | Details |
| 3-Methyl-3-(methylsulfanyl)-2-oxo-2,3-dihydro-1H-indole-7-carbonitrile | C11H10N2OS | 1955515-72-6 | Details |
| [3-(5-Chloropyridin-2-yl)phenyl]methanol | C12H10ClNO | 1349715-47-4 | Details |
| 4-{[(Propan-2-yl)amino]methyl}benzonitrile | C11H14N2 | 91350-01-5 | Details |
| Methyl 2-[4-(4-piperidinyloxy)phenyl]acetate hydrochloride | C14H20ClNO3 | 811813-40-8 | Details |
| 1-[(1-Aminobutan-2-yl)oxy]-3-fluorobenzene | C10H14FNO | 883539-37-5 | Details |
| N-(2-Methoxyphenyl)prop-2-enamide | C10H11NO2 | 104774-80-3 | Details |
| Methyl 2-methyl-a,g-dioxo-benzenebutanoate | C12H12O4 | 1037130-77-0 | Details |
| RAGE antibody (biotin) | Details |
| 4-Nitrophenyl 2-acetamido-3-O-acetyl-2-deoxy-b-D-glucopyranoside | C16H20N2O9 | 23262-57-9 | Details |
| Ganciclovir hydrate | C9H15N5O5 | 1359968-33-4 | Details |
| Methyl 2-[(4-chloro-3-nitrophenyl)formamido]propanoate | C11H11ClN2O5 | 1397000-09-7 | Details |
| 1-Amino-4-phenylbutan-2-one hydrochloride | C10H13NO.ClH | 31419-53-1 | Details |
| 4-?(2-?Bromoethoxy)?tetrahydro-2H-?thiopyran 1,?1-?dioxide | C7H13BrO3S | 2138424-47-0 | Details |
| H-EQDGSPPSEYTWFKD-OH | Details |
| Human lambda antibody | Details |
| 2-{[1-(1H-1,3-Benzodiazol-2-yl)ethyl]sulfanyl}acetic acid | C11H12N2O2S | 790270-73-4 | Details |
| 6-Methoxy-3,3-dimethyl-2,3,4,5-tetrahydropyridine | C8H15NO | 179685-59-7 | Details |
| 4-(Trifluoromethyl)umbelliferyl-b-D-cellotetraoside | C34H45F3O23 | 116981-93-2 | Details |
| 1-(2-Aminothiophen-3-yl)-2,2-dimethylpropan-1-one | C9H13NOS | 832113-73-2 | Details |
| 1-(4-Chlorophenyl)-1H-imidazole-2(3H)-thione | C9H7ClN2S | 17452-12-9 | Details |
| ZNF93 antibody | Details |
| 1-(Prop-2-yn-1-yl)piperidine-4-carboxylic acid hydrochloride | C9H14ClNO2 | 1193388-82-7 | Details |
| Scfd2 Blocking Peptide | Details |
| 3-(Methoxymethyl)-4-methyl-4,5-dihydro-1H-1,2,4-triazol-5-one | C5H9N3O2 | 135302-10-2 | Details |
| 2-(2-aminopyrimidin-4-yl)phenol | C10H9N3O | 31964-89-3 | Details |
| TSHR Blocking Peptide | Details |
| 4-[(Dimethylcarbamoyl)methanesulfonyl]benzoic acid | C11H13NO5S | 1016792-92-9 | Details |
| Ethyl 4-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,3-thiazole-2-carboxylate | C13H10N4O3S | 1803589-99-2 | Details |
| N-Pyrazinylcarbonyl-L-phenylalanine methyl ester | C15H15N3O3 | 73058-37-4 | Details |
| 2-(5-Formyl-1,3-thiazol-2-yl)-2-methylpropanenitrile | C8H8N2OS | 1694603-12-7 | Details |
| TIMP2 protein | Details |
| SHP2 antibody (Tyr580) | Details |
| Teludipine-d6 | C28H38N2O6 | 1246833-02-2 | Details |
| 2-(3-Methyl-2,5-dioxoimidazolidin-1-yl)-N-phenylacetamide | C12H13N3O3 | 730253-01-7 | Details |
| C14orf177 Blocking Peptide | Details |
| 3-[[3-[(Dimethylamino)carbonyl]-2-hydroxyphenyl]amino]-4-[[(R)-1-(4-isopropylfuran-2-yl)propyl]amino]cyclobut-3-ene-1,2-dione | C23H27N3O5 | 473728-58-4 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||